Biovica: DiviTum is well placed at the SABCS conference (10-12 December) - Redeye

SABCS (San Antonio Breast Cancer Symposium) is a major annual US cancer conference, and this year, Biovica’s DiviTum test will be featured in seven accepted abstracts. The SABCS conference is also an excellent opportunity to meet new potential partners, as demonstrated by Biovica’s earlier track record. SABC is expected to have >10k attendees from >100 countries.

Länk till analysen i sin helhet: https://www.redeye.se/research/1061321/biovica-divitum-is-well-placed-at-the-sabcs-conference-10-12-december?utm_source=finwire&utm_medium=RSS